EIKN
Eikon Therapeutics, Inc.
7.30$
-1.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | +0.2% | -1.6% | – | |
| – | – | – | – | – | – | – | – | |
| – | +5.1% | +22.3% | -14.3% | +10.0% | +7.4% | +7.7% | – | |
| – | +6.3% | +173.4% | -61.8% | +16.2% | -3.6% | +3.7% | – | |
| – | +5.3% | +53.6% | -31.8% | +4.4% | +5.3% | +7.5% | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.